These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 10273830

  • 1. Developing an effective P & T Committee, Part 2.
    Abramowitz PW, Godwin HN, Latiolais CJ, McDougal TR, Miller WA, Ravin RL.
    Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Developing an effective P&T Committee, Part I.
    Abramowitz PW, Godwin HN, Latiolais CJ, McDougal TR, Miller WA, Ravin RL.
    Hosp Formul; 1985 Jul; 20(7):827-8, 837, 841-3 passim. PubMed ID: 10271920
    [Abstract] [Full Text] [Related]

  • 4. Improving pharmacy and therapeutics committee operations.
    Cohen MR, Klapp D, Miller KB, Shaffer VL, Slotfeldt M, Miller DE.
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [Abstract] [Full Text] [Related]

  • 5. P & T Committee interview: communication and education contribute to an effective formulary system.
    Hinthorn D, Godwin H.
    Hosp Formul; 1989 May; 24(5):281-4, 286-7. PubMed ID: 10292977
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The evolution of an effective P & T Committee: advice from the chairman.
    Williams RR.
    Hosp Formul; 1986 Dec; 21(12):1232-5, 1243. PubMed ID: 10279772
    [Abstract] [Full Text] [Related]

  • 8. P & T Committee formulary requests: criteria for admission.
    Weintraub M, Guttmacher L.
    Hosp Formul; 1984 Oct; 19(10):975-7, 980. PubMed ID: 10268315
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effective decision-making in a changing healthcare environment: a P & T Committee interview.
    Zoloth A, Yon JL, Woolf R.
    Hosp Formul; 1989 Feb; 24(2):85-7, 90, 93 passim. PubMed ID: 10291815
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. P & T Committee role in advocating rational therapeutics.
    Borreson R.
    Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preparing the P & T committee agenda for new drug requests.
    Standish RC, Evans PJ, Bell JE.
    Hosp Formul; 1984 Sep; 19(9):792, 795-800. PubMed ID: 10267929
    [Abstract] [Full Text] [Related]

  • 18. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW, Keith TD, Foster MT.
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. An inside look at the UCLA P&T committee: how does it influence prescribing practices?
    Conolly ME.
    Hosp Formul; 1986 Feb; 21(2):214-7. PubMed ID: 10275576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.